Natural Selection and Early Changes of Phenotype of Tumor Cells in
vivo: Acquisition of New Defense Mechanisms
G. I. Deichman
Institute of Carcinogenesis, Blokhin Russian Cancer Research Center,
Russian Academy of Medical Sciences, Kashirskoe Shosse 24, Moscow,
115478 Russia; fax: (095) 324-1205; E-mail:
antitum@space.ru
Received October 5, 1999
This review summarizes results obtained in the author's and
collaborating laboratories within the last decade and is designed to
attract the attention of researchers to discrete biochemical mechanisms
of protection acquired in vivo by cells of malignant tumors
against effectors of innate antitumor immunity. Tumor progression in
vivo is associated with the appearance and selection of tumor cells
with new specific characteristics: a high level of
H2O2-catabolizing (antioxidant) activity
(H2O2CA) and the ability for immediate
release of E2-type prostaglandin (PGES) on
contact with natural killers, macrophages, and neutrophils; the
expression of the [H2O2CA +
PGES] phenotype provides the tumor cells with two mechanisms
of local protection against effectors of innate and acquired antitumor
immunity. This results in a 10-100-fold less effective rejection of
tumor cells in immune and normal animals and corresponding increase of
tumorigenicity. The in vitro transformation of normal
fibroblasts, spontaneous or induced by oncogenes LTSV40,
E1a,b, Ha-ras, myc, and also by
p53175 and bcl-2 does not result in the
[H2O2CA + PGES] phenotype
expression, but during subsequent in vivo growth of the
above-mentioned transformants the selection of tumor cells of the
[H2O2CA + PGES] phenotype
is correlated with a 30-200-fold increase in their tumorigenicity
(accompanied or not accompanied by spontaneous metastatic activity).
Unlike the transformation induced by the above-mentioned oncogenes, the
transformation of normal cells by the v-src gene results in the
[H2O2CA + PGES] phenotype
expression. The data presented confirm the determining role of the
v-src gene in the expression of the
[H2O2CA + PGES] phenotype.
In various primary viral carcinogenesis (SV40, SA7(C8)) the natural
selection of cells expressing the
[H2O2CA + PGES] phenotype
begins even within the latent period and can be completed by the
appearance of primary tumors.
KEY WORDS: transformation, carcinogenesis, in vivo tumor
progression, antioxidant and PGE2-releasing activity of
tumor cells, protection mechanisms of tumor cells, innate and specific
antitumor immunity